Trial intelligence / Profile preview

Cetirizine Dry Syrup in Children with Atopic Dermatitis

NCT00257569Phase 3Completed

Sponsor
GSK
Start
Aug 2005
Modality
Small Molecules
01

Overview

A Phase 3 trial of cetirizine in atopic dermatitis (AD), sponsored by GSK. Started Aug 2005; status: completed.

02

Drugs

cetirizine
03

Conditions

atopic dermatitis (AD)

Beyond the preview

Go deeper on NCT00257569.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00257569.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call